SELENOP and Other metabolic disease: If not due to unmeasured confounding, our results indicate a possible adverse effect of high concentrations of selenoprotein P in dementia etiology, in line with deleterious effects recently ascribed to selenoprotein P with reference to metabolic disease risk8–10,18,37.